These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8384109)
1. De novo absence status epilepticus as a benzodiazepine withdrawal syndrome. Thomas P; Lebrun C; Chatel M Epilepsia; 1993; 34(2):355-8. PubMed ID: 8384109 [TBL] [Abstract][Full Text] [Related]
2. Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal. Kanemoto K; Miyamoto T; Abe R Seizure; 1999 Sep; 8(6):364-6. PubMed ID: 10512781 [TBL] [Abstract][Full Text] [Related]
3. Alprazolam withdrawal delirium unresponsive to diazepam: case report. Zipursky RB; Baker RW; Zimmer B J Clin Psychiatry; 1985 Aug; 46(8):344-5. PubMed ID: 2862137 [TBL] [Abstract][Full Text] [Related]
4. De Novo Myoclonic Status Epilepticus After Benzodiazepine Withdrawal. Vicente Ferreira Naves P; Calderaro M; Caboclo LO Clin Neuropharmacol; 2018; 41(4):142-144. PubMed ID: 29851670 [TBL] [Abstract][Full Text] [Related]
5. Clinical Reasoning: A 62-year-old woman with bizarre behavior and recurrent episodes of behavioral arrest. Briglia H; Kohler S; Langer JE Neurology; 2016 Feb; 86(7):e62-5. PubMed ID: 26880814 [No Abstract] [Full Text] [Related]
6. Acute confusion in a chronic benzodiazepine patient. Withdrawal-related nonconvulsive status epilepticus misdiagnosed as acute intoxication. Primavera A; Cocito L Gen Hosp Psychiatry; 1995 Nov; 17(6):460-2. PubMed ID: 8714811 [No Abstract] [Full Text] [Related]
7. De novo absence status of late onset following withdrawal of lorazepam: a case report. Fernández-Torre JL Seizure; 2001 Sep; 10(6):433-7. PubMed ID: 11700998 [TBL] [Abstract][Full Text] [Related]
8. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines. Chouinard G; Labonte A; Fontaine R; Annable L Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):669-73. PubMed ID: 6141609 [TBL] [Abstract][Full Text] [Related]
9. Benzodiazepine dependence and its treatment with low dose flumazenil. Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253 [TBL] [Abstract][Full Text] [Related]
17. The benzodiazepine antagonist Ro 15-1788 does not antagonize the ethanol withdrawal syndrome. Adinoff B; Majchrowicz E; Martin PR; Linnoila M Biol Psychiatry; 1986 Jun; 21(7):643-9. PubMed ID: 3011130 [TBL] [Abstract][Full Text] [Related]
18. The impact of diazepam's discovery on the treatment and understanding of status epilepticus. Goodkin HP; Kapur J Epilepsia; 2009 Sep; 50(9):2011-8. PubMed ID: 19674049 [TBL] [Abstract][Full Text] [Related]
19. Effects of flumazenil in the treatment of benzodiazepine withdrawal--a double-blind pilot study. Saxon L; Hjemdahl P; Hiltunen AJ; Borg S Psychopharmacology (Berl); 1997 May; 131(2):153-60. PubMed ID: 9201803 [TBL] [Abstract][Full Text] [Related]
20. A double-blind randomised crossover trial of low-dose flumazenil for benzodiazepine withdrawal: A proof of concept. MacDonald T; Gallo AT; Basso-Hulse G; Bennett KS; Hulse GK Drug Alcohol Depend; 2022 Jul; 236():109501. PubMed ID: 35644071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]